Skip to content

RLMD - RELMADA THERAPEUTICS, INC. - AlphaYou

Discover Compare Pricing

Sign in Sign up

Home Smart money Buy calls Analyze

Back to stock searchR

Relmada Therapeutics Inc

RLMD · NASDAQ

Save to watchlist

Price is syncing

Reported smart-money activity for this stock is still below.

R

RLMDRelmada Therapeutics Inc

Overview

No source-backed view yet. This page is available for price, fundamentals, and future receipts as coverage warms.

Key stats

Aug 20

52-wk high: $8.00
52-wk low: $0.60
Prev close: $4.44
Mkt cap: $515.2M
Beta: 0.83
P/S: 9001.9x

Smart money

8 funds hold a position.

Real smart money

Funds holding this stock

8 holders

Combined position$129.0M

MI
Millennium
Israel Englander · Q2 2026 13F
$16.3M
position
MW
Marshall Wace
Q2 2026 13F

Earnings

Reported Aug 6, 2026

Earnings came in 47.6% above what analysts expected.

Documents

Quarterly report10-Q Annual report10-K

Financials

Fundamentals

Is the business strong?

This company is running thin margins.

Net margin: 0.0%
Market cap: $515M

Valuation

P/S9001.90
P/B2.50

Quality

Operating margin0.0%
ROE

Technicals

Technicals

Price structure

No data yet

Technicals sync when verified market data is available. No sample data is shown.

Company

Symbol: RLMD
Exchange: NASDAQ
Sector: HEALTHCARE
Industry: BIOTECHNOLOGY
Market cap: $515.22M
Beta: 0.83

Analysts

What do analysts expect?

Analyst target and ratings are on paid plans

See the 12-month consensus target and the buy/hold/sell rating split.

Unlock the full results

Research hubs
About
Editorial policy
Methodology
Source coverage
Corrections

Privacy
Terms
Refunds
Disclaimer

© 2026 AlphaYou. All rights reserved.Not financial advice. Do your own research. Informational data only; past performance does not predict future results.

P/B

2.5x

Profit margin

+0.0%

Op margin

+0.0%

ROE

-25.6%

$15.5M

position

BA

Balyasny

Dmitry Balyasny · Q2 2026 13F

$10.5M

position

5 more holders

Lite opens all of them for $16.50/month, paid yearly.

Unlock all 5 holders

Coverage gaps for RLMD

No recent insider trade
No recent Congress trade
No recent market-voice mention

Earnings per share

-$0.11+47.6%

-$0.21 expected

Next report

What the street expects next

-25.6%

ROA-14.4%

Growth

Beta0.83